GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Savara Inc (STU:YB4P) » Definitions » Cyclically Adjusted Book per Share

Savara (STU:YB4P) Cyclically Adjusted Book per Share : €5.88 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Savara Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Savara's adjusted book value per share for the three months ended in Mar. 2024 was €0.811. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €5.88 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Savara's average Cyclically Adjusted Book Growth Rate was -38.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -38.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -32.70% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -29.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Savara was -2.90% per year. The lowest was -38.00% per year. And the median was -27.05% per year.

As of today (2024-06-05), Savara's current stock price is €3.64. Savara's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €5.88. Savara's Cyclically Adjusted PB Ratio of today is 0.62.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Savara was 0.61. The lowest was 0.01. And the median was 0.06.


Savara Cyclically Adjusted Book per Share Historical Data

The historical data trend for Savara's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Savara Cyclically Adjusted Book per Share Chart

Savara Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.62 27.42 17.63 11.32 6.93

Savara Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.93 7.46 8.07 6.93 5.88

Competitive Comparison of Savara's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Savara's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Savara's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Savara's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Savara's Cyclically Adjusted PB Ratio falls into.



Savara Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Savara's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.811/131.7762*131.7762
=0.811

Current CPI (Mar. 2024) = 131.7762.

Savara Quarterly Data

Book Value per Share CPI Adj_Book
201406 21.590 100.560 28.292
201409 19.276 100.428 25.293
201412 20.883 99.070 27.777
201503 20.322 99.621 26.881
201506 16.214 100.684 21.221
201509 12.785 100.392 16.782
201512 9.382 99.792 12.389
201603 6.741 100.470 8.841
201606 4.912 101.688 6.365
201609 3.532 101.861 4.569
201612 -9.345 101.863 -12.089
201703 1.118 102.862 1.432
201706 2.933 103.349 3.740
201709 2.568 104.136 3.250
201712 3.304 104.011 4.186
201803 2.483 105.290 3.108
201806 2.296 106.317 2.846
201809 2.876 106.507 3.558
201812 2.707 105.998 3.365
201903 2.515 107.251 3.090
201906 2.566 108.070 3.129
201909 2.353 108.329 2.862
201912 1.802 108.420 2.190
202003 1.554 108.902 1.880
202006 1.409 108.767 1.707
202009 1.202 109.815 1.442
202012 0.977 109.897 1.172
202103 1.295 111.754 1.527
202106 1.206 114.631 1.386
202109 1.159 115.734 1.320
202112 1.121 117.630 1.256
202203 1.087 121.301 1.181
202206 1.054 125.017 1.111
202209 1.032 125.227 1.086
202212 0.892 125.222 0.939
202303 0.805 127.348 0.833
202306 0.709 128.729 0.726
202309 1.015 129.860 1.030
202312 0.932 129.419 0.949
202403 0.811 131.776 0.811

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Savara  (STU:YB4P) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Savara's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=3.64/5.88
=0.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Savara was 0.61. The lowest was 0.01. And the median was 0.06.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Savara Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Savara's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Savara (STU:YB4P) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Savara Inc (STU:YB4P) » Definitions » Cyclically Adjusted Book per Share
Traded in Other Exchanges
Address
6836 Bee Cave Road, Building I, Suite 205, Austin, TX, USA, 78746
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's lead program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Savara (STU:YB4P) Headlines

No Headlines